Specialty Drug, Specialty Pharmacy
Arcutis Biotherapeutics’ Launches ZORYVE to Treat Plague Psoriasis
06
Sep
Sep
Arcutis recently announced that ZORYVE (roflumilast) cream 0.3% for topical use is now available in the United States for the treatment of plaque psoriasis in people aged 12 and older